| |
| |
|
| Insider
Information: |
Kim Dennis D |
| Relationship: |
Chief Medical Officer |
| City: |
La Jolla |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
66,643 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$674,393 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
66,643 |
|
|
| Total
Value |
$674,393 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
3.0
|
| Percentage
Gain/Loss : |
 16.7%
|
436.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orexigen Therapeutics, Inc. |
OREX |
Sr. VP, Corporate Deve... |
2009-03-24 |
25,200 |
|
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Chief Medical Officer |
2017-07-11 |
21,443 |
2015-09-14 |
0 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
Chief Medical Officer |
2023-04-17 |
20,000 |
2022-01-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2023-04-17 |
4 |
S |
$9.54 |
$1,070,536 |
D/D |
(112,219) |
20,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2023-04-17 |
4 |
OE |
$4.37 |
$490,397 |
D/D |
112,219 |
132,219 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2023-04-13 |
4 |
S |
$8.98 |
$69,880 |
D/D |
(7,781) |
20,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2023-04-13 |
4 |
OE |
$4.37 |
$34,003 |
D/D |
7,781 |
27,781 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2023-03-28 |
4 |
S |
$8.99 |
$899 |
D/D |
(100) |
20,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2023-03-28 |
4 |
OE |
$4.37 |
$437 |
D/D |
100 |
20,100 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Chief Medical Officer |
• – – |
2022-01-19 |
4 |
B |
$3.04 |
$60,800 |
D/D |
20,000 |
20,000 |
2.74 |
% |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-07-11 |
4 |
B |
$3.39 |
$33,900 |
D/D |
10,000 |
21,443 |
2.74 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-05-11 |
4 |
B |
$4.40 |
$43,120 |
D/D |
9,800 |
11,443 |
2.74 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-05-10 |
4 |
B |
$4.40 |
$880 |
D/D |
200 |
1,643 |
2.66 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-17 |
4 |
OE |
$1.57 |
$14,353 |
D/D |
9,142 |
9,142 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-17 |
4/A |
AS |
$40.00 |
$365,680 |
D/D |
(9,142) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-17 |
4 |
S |
$40.00 |
$365,680 |
D/D |
(9,142) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-15 |
4 |
OE |
$1.57 |
$47,516 |
D/D |
30,265 |
30,265 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-15 |
4 |
S |
$40.00 |
$1,210,600 |
D/D |
(30,265) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-15 |
4/A |
AS |
$40.00 |
$1,210,600 |
D/D |
(30,265) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-14 |
4/A |
AS |
$40.00 |
$23,720 |
D/D |
(593) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-14 |
4 |
S |
$40.00 |
$23,720 |
D/D |
(593) |
0 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-09-14 |
4 |
OE |
$1.57 |
$931 |
D/D |
593 |
593 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Sr. VP, Corporate Development |
• – – |
2009-03-24 |
4 |
A |
$2.65 |
$26,500 |
D/D |
10,000 |
25,200 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Sr. VP, Corporate DevelopmentO |
• – – |
2009-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,200 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
